Table. Anti–Vascular Endothelial Growth Factor Injections Administered to Medicare Part B Population in 2015.
| Injections | Total No. of Intravitreal Injections | Aflibercept | Ranibizumab | Bevacizumab |
|---|---|---|---|---|
| Total No. of injections | 2 574 124a | 870 843 | 697 412 | 1 147 432 |
| Total No. (%) of injections administered by ophthalmologists with highest volume of intravitreal injections | 332 203 (12.9) | 153 467 (17.6) | 216 142 (31.0) | 225 083 (19.6) |
| Mean No. of injections administered by ophthalmologists with highest volume of intravitreal injections | 3322 | 1535 | 2161 | 2251 |
a
Total excludes clinicians administering 10 or fewer intravitreal injections in 2015.